The Clinical Importance of Changes in the 0 to 10 Numeric Rating Scale for Worst, Least, and Average Pain Intensity: Analyses of Data from Clinical Trials of Duloxetine in Pain Disorders
To access this article, please choose from the options below
This work utilized data from clinical trials sponsored by Eli Lilly and Company, Indianapolis, Indiana.
PII: S1526-5900(09)00588-4
doi:10.1016/j.jpain.2009.06.007
© 2010 American Pain Society. Published by Elsevier Inc. All rights reserved.
